Currently, there are more than 3,000 gene therapy or recombinant vector vaccine pipeline products in active development between the discovery and ...
https://www.google.com/url?rct=j&sa=t&url=https://www.thepharmaletter.com/article/astrazeneca-and-j-j-face-viral-vector-shortages-for-covid-19-vaccines-says-analyst&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGQG3c02ZjP6-xQUcCweCH2NKgn5Q
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.